Shenzhen Hepalink Pharmaceutical Co Ltd (002399) — Cash Flow Quality Index
Shenzhen Hepalink Pharmaceutical Co Ltd (002399) has a Cash Flow Quality Index of 3.03x as of September 2025. Operating cash flow of CN¥399.43 Million exceeds net income of CN¥131.73 Million, indicating high earnings quality where cash backs reported profits. Explore 002399 operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shenzhen Hepalink Pharmaceutical Co Ltd Cash Flow Quality Index (2007–2025)
Historical Cash Flow Quality Index for Shenzhen Hepalink Pharmaceutical Co Ltd across 18 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shenzhen Hepalink Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shenzhen Hepalink Pharmaceutical Co Ltd (2007–2025)
Year-by-year earnings quality comparison for Shenzhen Hepalink Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Shenzhen Hepalink Pharmaceutical Co Ltd (002399) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.90x | CN¥1.71 Billion | CN¥349.49 Million | ▲ +39.6% |
| 2024 | 3.51x | CN¥2.19 Billion | CN¥624.92 Million | ▲ +431.7% |
| 2022 | -1.06x | CN¥-756.61 Million | CN¥714.69 Million | ▼ -3627.0% |
| 2021 | -0.03x | CN¥-6.63 Million | CN¥233.38 Million | ▼ -177.8% |
| 2020 | 0.04x | CN¥37.28 Million | CN¥1.02 Billion | ▲ +116.7% |
| 2019 | -0.22x | CN¥-227.60 Million | CN¥1.04 Billion | ▼ -119.3% |
| 2018 | 1.13x | CN¥667.87 Million | CN¥592.18 Million | ▲ +132.7% |
| 2017 | -3.44x | CN¥-407.12 Million | CN¥118.19 Million | ▼ -484.3% |
| 2016 | 0.90x | CN¥346.07 Million | CN¥386.12 Million | ▼ -43.0% |
| 2015 | 1.57x | CN¥893.71 Million | CN¥568.08 Million | ▼ -42.2% |
| 2014 | 2.72x | CN¥912.80 Million | CN¥335.33 Million | ▲ +102.7% |
| 2013 | 1.34x | CN¥420.97 Million | CN¥313.42 Million | ▲ +74.7% |
| 2012 | 0.77x | CN¥473.89 Million | CN¥616.55 Million | ▼ -66.1% |
| 2011 | 2.27x | CN¥1.41 Billion | CN¥618.94 Million | ▲ +673.4% |
| 2010 | 0.29x | CN¥354.86 Million | CN¥1.21 Billion | ▼ -33.2% |
| 2009 | 0.44x | CN¥355.81 Million | CN¥809.06 Million | ▲ +76.9% |
| 2008 | 0.25x | CN¥40.13 Million | CN¥161.39 Million | ▲ +22.4% |
| 2007 | 0.20x | CN¥13.85 Million | CN¥68.16 Million | — |